Advertisement
News
Advertisement

Santarus to Webcast Analyst Day and Investor Briefing Presentation on January 19

Wed, 01/19/2011 - 2:41am
Bio-Medicine.Org

SAN DIEGO, Jan. 19, 2011 /PRNewswire/ -- Santarus, Inc. (Nasdaq: SNTS) announces that a live audio webcast and accompanying slide presentation will be provided for its Analyst Day and Investor Briefing.  

Details of the event are as follows:What:Santarus Analyst Day and Investor BriefingWhen:Today, Wednesday, January 19, 2011 at 4:15 p.m. Eastern timeWhere:www.santarus.com (under the Investor Relations link)AGENDA

Strategic Overview and 2011 Financial Outlook

Gerald T. Proehl, President, Chief Executive Officer & Director, Santarus, Inc.

CYCLOSET® - Clinical/Medical Background

Dr. J. Michael Gaziano, Chief, Division of Aging, Brigham & Women’s Hospital,

Professor of Medicine, Harvard Medical School

ULTESA™ (Budesonide MMX®) – Overview and Top-line Phase III Clinical Study Results

Dr. Simon P.L. Travis, Consultant Gastroenterologist,

Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford, UK

Ulcerative Colitis – Treatment Perspective

Dr. William J. Sandborn, Professor of Clinical Medicine and Chief of the Division of Gastroenterology,

University of California, San Diego

RHUCIN® and Hereditary Angioedema (HAE)

Dr. Bruce L. Zuraw, Professor of Medicine and Chief, Allergy and Immunology, University of California, San Diego,

Research Scientist, San Diego VA Healthcare

SAN-300 (anti-VLA-1 antibody)

Dr. Mark C. Totoritis, Senior Vice President, Biologics, Santarus, Inc.

Wrap-up/Question & Answer Session

Gerald T. Proehl, President, Chief Executive Officer & Director, Santarus, Inc.

How:Live over the Internet – Simply log on t

'/>"/>

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading